Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients Editorial

  

Authors:	Al Mahmasani, L.; Abou-Alfa, G. K.
Title:	Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients
Keywords:	vasculotropin; overall survival; sorafenib; bevacizumab; sunitinib; quality of life; inflammation; editorial; risk factor; health care; cardiovascular diseases; pazopanib; health care personnel; lactate dehydrogenase; tumor growth; axitinib; cerebrovascular accident; pertuzumab; scientific literature; nitric oxide; prostacyclin; cellular senescence; cabozantinib; lenvatinib; ramucirumab; cancer; human; antiangiogenic agents
Journal Title:	American Heart Journal Plus
Volume:	43
ISSN:	2666-6022
Publisher:	Elsevier Inc.
Date Published:	2024-07-01
Start Page:	100406
Language:	English
DOI:	10.1016/j.ahjo.2024.100406
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195395207&doi=10.1016%2fj.ahjo.2024.100406&partnerID=40&md5=66038fdc19eefedbfbf1102340016cca
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/216807